• LAST PRICE
    1.4100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 1.4100
  • Day Range
    ---
  • 52 Week Range
    Low 1.3600
    High 26.8500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.46
TimeVolumeATXI
09:32 ET2801.4188
09:33 ET10801.46
09:37 ET50001.47
10:06 ET2671.4489
10:08 ET17801.42
10:13 ET323931.4799
10:15 ET140371.475
10:20 ET42001.4699
10:22 ET59751.4516
10:24 ET3001.46
10:26 ET5001.4511
10:29 ET64591.42
10:31 ET36241.4364
10:38 ET10001.4386
10:40 ET50961.47
10:44 ET2271.4572
11:20 ET40001.4302
11:32 ET13001.435
11:34 ET30001.44
11:36 ET10001.44
11:38 ET12001.43
11:39 ET10001.4399
11:41 ET49951.43
11:43 ET56001.4385
11:45 ET137201.39
11:48 ET1001.4099
11:52 ET167801.3999
11:54 ET1001.4
11:57 ET23001.4094
11:59 ET17001.41
12:06 ET10001.4001
12:08 ET54701.41
12:10 ET36001.3895
12:12 ET1001.3899
12:14 ET9501.3901
12:15 ET14001.38
12:17 ET1001.39
12:21 ET1001.3907
12:24 ET1001.4
12:26 ET3321.4
12:32 ET23991.39
12:35 ET22001.3901
12:39 ET1001.4
12:44 ET1001.39
12:50 ET3001.4
12:51 ET4501.4004
12:57 ET9071.4
01:00 ET19131.41
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesATXI
Avenue Therapeutics Inc
6.7M
-0.4x
---
United StatesWINT
Windtree Therapeutics Inc
6.7M
-0.1x
---
United StatesTENX
Tenax Therapeutics Inc
6.7M
-0.3x
---
United StatesQRON
Qrons Inc
6.8M
-7.3x
---
United StatesKZIA
Kazia Therapeutics Ltd
10.1M
-0.5x
---
United StatesAMPE
Ampio Pharmaceuticals Inc
6.5M
-0.3x
---
As of 2022-11-28

Company Information

Avenue Therapeutics, Inc. is a specialty pharmaceutical company. The Company seeks to develop and commercialize its product principally for use in the acute/intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, for the treatment of post-operative acute pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works through the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. These opioid and non-opioid modes of action are synergistic, providing multimodal therapy with the use of a single drug. Tramadol is marketed as an oral agent indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Ultracet, a combination product containing tramadol and acetaminophen, is also marketed in the United States (Ortho-McNeil-Janssen).

Contact Information

Headquarters
2 Gansevoort St Fl 9NEW YORK, NY, United States 10014-1667
Phone
781-652-4500
Fax
302-531-3150

Executives

Executive Chairman of the Board of Directors
Lindsay Rosenwald
Chief Executive Officer
Alexandra Maclean
Interim Chief Financial Officer, Chief Operating Officer
David Jin
Director
Jaideep Gogtay
Director
Elizabeth Ingram

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.7M
Revenue (TTM)
$0.00
Shares Outstanding
4.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.63
EPS
$-3.66
Book Value
$2.45
P/E Ratio
-0.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.